DCGI approves anti-COVID drug developed by DRDO for emergency use

Delhi, May 8: An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad, said an official release. According to a statement of the Ministry of Defence, clinical […]

Continue Reading